Edition:
India

ICON PLC (ICLR.OQ)

ICLR.OQ on NASDAQ Stock Exchange Global Select Market

113.27USD
12 Jan 2018
Change (% chg)

-- (--)
Prev Close
$113.27
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
96,576
52-wk High
$124.33
52-wk Low
$76.50

Latest Key Developments (Source: Significant Developments)

Icon Expects FY2018 Revenue In Range Of $1,870 Mln - $1,930 Mln
Tuesday, 9 Jan 2018 

Jan 9 (Reuters) - Icon Plc ::ICON ISSUES FINANCIAL GUIDANCE FOR FULL YEAR 2018.- ‍FULL YEAR 2018 REVENUE GUIDANCE IN RANGE OF $1,870 - $1,930 MILLION, REPRESENTING GROWTH OF 7 - 10%​.- ‍FULL YEAR 2018 EARNINGS PER SHARE GUIDANCE IN RANGE OF $5.89 - $6.09, REPRESENTING GROWTH OF 10 - 13%​.- SEES ‍CIRCA $360 MILLION OF FREE CASH FLOW AND CAPITAL EXPENDITURES OF CIRCA $50 MILLION​ FOR 2018.- WITH RESPECT TO 2017, CO CONFIRMED ITS CURRENT GUIDANCE, OF REVENUE IN RANGE OF $1,740 - $1,770 MILLION AND EARNINGS IN RANGE OF $5.30 - $5.40.FY2017 EARNINGS PER SHARE VIEW $5.37, REVENUE VIEW $1.76 BILLION -- THOMSON REUTERS I/B/E/S.FY2018 EARNINGS PER SHARE VIEW $5.96, REVENUE VIEW $1.89 BILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Icon Plc Q3 EPS $1.35
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Icon Plc :Qtrly net revenue increased 4.8% to $440 million compared to same quarter last year​.Qtrly ‍earnings per share increased by 13.4% to $1.35 per share​.Earnings guidance for 2017 increased from a range of $5.18 - $5.38 to $5.30 - $5.40 and revenue guidance re-affirmed in range of $1,740 - 1,770 million.Grew our backlog by 13% year on year to nearly $5 billion at quarter-end​.Q3 earnings per share view $1.32, revenue view $436.4 million -- Thomson Reuters I/B/E/S.FY2017 earnings per share view $5.32, revenue view $1.75 billion -- Thomson Reuters I/B/E/S.  Full Article

ICON signed new three-year agreement with Pfizer Inc.
Friday, 10 Jun 2016 

ICON Plc : Signed a three-year agreement with Pfizer Inc. . Pfizer has right to extend term for up to an additional two years. . Financial details of agreement were not disclosed. .New agreement builds on existing relationship, where icon provides planning, execution, management and conduct of clinical trials services.  Full Article

Icon announces service agreement with Pfizer
Friday, 10 Jun 2016 

Press Release : Icon announces service agreement with Pfizer . Financial details of agreement were not disclosed . Icon plc says Pfizer has right to extend term for up to an additional two years .Icon announces service agreement with Pfizer.  Full Article

Thomas Lynch Notifies ICON PLC of His Retirement as Chairman
Tuesday, 29 Mar 2016 

ICON PLC:Says Thomas Lynch, non-executive chairman of the board of directors, has notified ICON that he will retire as chairman on 31 March 2016 and will not stand for re-election to the board at co's annual general meeting in July 2016.ICON's senior independent director, Declan McKeon, will serve as acting chairman from Lynch's retirement as chairman and board will initiate process to appoint new chairman.  Full Article

ICON PLC gives FY 2016 guidance
Tuesday, 23 Feb 2016 

ICON PLC:Expects FY 2016 revenue in the range of $1,670 - $1,730 million.Expects FY 2016 earnings per share (EPS) in the range of $4.60 - $4.80.  Full Article

BRIEF-Icon Expects FY2018 Revenue In Range Of $1,870 Mln - $1,930 Mln

* - ‍FULL YEAR 2018 REVENUE GUIDANCE IN RANGE OF $1,870 - $1,930 MILLION, REPRESENTING GROWTH OF 7 - 10%​